WJTC WJTC/UTV44 - Search Results
How A Teaspoon Of Peanut Butter Helps Detect The Early Stages Of Alzheimer's Disease
The newest tool in the fight against Alzheimers disease could already be in your cupboard because peanut butter has been found to help detect the illness.Researchers at the University of Florida used the sandwich spread in a sniff test to determine patients loss of smell in one nostril compared to the other.They found that those in the early stages of Alzheimers disease lose their sense of smell in the left nostril more quickly than in the right and peanut butter is the perfect substance with which to detect the problem.Thats thanks to its status as a pure odorant, meaning its smell is detected exclusively by our olfactory nerve. Most smells are also detected with our trigeminal nerve, which is responsible for sensation in the face.But its the olfactory nerve thats important in Alzheimers research. Degradation in the olfactory center of the brain is one of the first signs of the disease, but detecting it isnt easy.Researcher Jennifer Stamps at UF McKnight Brain Institute Center for Smell and Taste conducted the experiment by holding a ruler to the noses of patients with Alzheimers and other forms of dementia.One nostril at a time, with the other one held shut, Stamps then slowly moved a tablespoon of peanut butter closer to the nostril in centimeter increments.The patients signaled when they could smell the peanut butter.What Stamps found is that Alzheimers patients, unlike those with other forms of dementia, had better smell in the right nostril than in the left. On average, patients could smell the peanut butter at about 20 centimeters from their right nostril versus 10 centimeters from their left.There was a big asymmetry there, Stamps said.Her findings could translate into a fast and easy way to detect the initial stages of Alzheimers, so that it can be slowed with drugs as early as possible.At the moment, we can use this test to confirm diagnosis, Stamps said. But we plan to study patients with mild cognitive impairment to see if this test might be used to predict which patients are going to get Alzheimers disease.